26 天on MSN
PDS Biotech outlines accelerated regulatory timeline after VERSATILE-003 protocol amendment
Q4 2025 Management View Frank Bedu-Addo, President, CEO & Director, detailed that "the fourth quarter of 2025 capped a period of important progress for PDS Biotech, marked by meaningful advances ...
Edesa Biotech Inc. (NASDAQ:EDSA) is one of the unstoppable stocks that could double your money. On March 26, Edesa reaffirmed ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果